Advertisement

Index by author

September 01, 2019; Volume 370,Issue 3

  1. Barry, Mary

    1. Liraglutide Attenuates Preestablished Atherosclerosis in Apolipoprotein E–Deficient Mice via Regulation of Immune Cell Phenotypes and Proinflammatory Mediators
      Robyn Bruen, Seán Curley, Sarina Kajani, Gina Lynch, Marcella E. O’Reilly, Eugène T. Dillon, Eoin P. Brennan, Mary Barry, Stephen Sheehan, Fiona C. McGillicuddy and Orina Belton
      Journal of Pharmacology and Experimental Therapeutics September 2019, 370 (3) 447-458; DOI: https://doi.org/10.1124/jpet.119.258343

  2. Basta, A.

    1. Cellular Vesicles: New Insights in Engineering Methods, Interaction with Cells and Potential for Brain Targeting
      A. Marazioti, K. Papadia, M. Kannavou, M. Spella, A. Basta, A.-L. de Lastic, M. Rodi, A. Mouzaki, M. Samiotaki, G. Panayotou, G.T. Stathopoulos and S.G. Antimisiaris
      Journal of Pharmacology and Experimental Therapeutics September 2019, 370 (3) 772-785; DOI: https://doi.org/10.1124/jpet.119.257097

  3. Batra, Surinder K.

    1. Combination Therapies and Drug Delivery Platforms in Combating Pancreatic Cancer
      Fan Lei, Xinyuan Xi, Surinder K. Batra and Tatiana K. Bronich
      Journal of Pharmacology and Experimental Therapeutics September 2019, 370 (3) 682-694; DOI: https://doi.org/10.1124/jpet.118.255786

  4. Belton, Orina

    1. Liraglutide Attenuates Preestablished Atherosclerosis in Apolipoprotein E–Deficient Mice via Regulation of Immune Cell Phenotypes and Proinflammatory Mediators
      Robyn Bruen, Seán Curley, Sarina Kajani, Gina Lynch, Marcella E. O’Reilly, Eugène T. Dillon, Eoin P. Brennan, Mary Barry, Stephen Sheehan, Fiona C. McGillicuddy and Orina Belton
      Journal of Pharmacology and Experimental Therapeutics September 2019, 370 (3) 447-458; DOI: https://doi.org/10.1124/jpet.119.258343

  5. Bernhard, Ana

    1. TransCon CNP, a Sustained-Release C-Type Natriuretic Peptide Prodrug, a Potentially Safe and Efficacious New Therapeutic Modality for the Treatment of Comorbidities Associated with Fibroblast Growth Factor Receptor 3–Related Skeletal Dysplasias
      Vibeke Miller Breinholt, Caroline E. Rasmussen, Per Holse Mygind, Mads Kjelgaard-Hansen, Frank Faltinger, Ana Bernhard, Joachim Zettler and Ulrich Hersel
      Journal of Pharmacology and Experimental Therapeutics September 2019, 370 (3) 459-471; DOI: https://doi.org/10.1124/jpet.119.258251

  6. Blanco-prieto, María J.

    1. Long-Term Engraftment of Human Cardiomyocytes Combined with Biodegradable Microparticles Induces Heart Repair
      Laura Saludas, Elisa Garbayo, Manuel Mazo, Beatriz Pelacho, Gloria Abizanda, Olalla Iglesias-Garcia, Angel Raya, Felipe Prósper and María J. Blanco-Prieto
      Journal of Pharmacology and Experimental Therapeutics September 2019, 370 (3) 761-771; DOI: https://doi.org/10.1124/jpet.118.256065
    2. Therapeutic Opportunities in Neuroblastoma Using Nanotechnology
      Carlos Rodríguez-Nogales, Rosa Noguera, Patrick Couvreur and María J. Blanco-Prieto
      Journal of Pharmacology and Experimental Therapeutics September 2019, 370 (3) 625-635; DOI: https://doi.org/10.1124/jpet.118.255067

  7. Blobaum, Anna L.

    1. Structure-Activity Relationships, Pharmacokinetics, and Pharmacodynamics of the Kir6.2/SUR1-Specific Channel Opener VU0071063
      Sujay V. Kharade, Juan Vicente Sanchez-Andres, Mark G. Fulton, Elaine L. Shelton, Anna L. Blobaum, Darren W. Engers, Christopher S. Hofmann, Prasanna K. Dadi, Louise Lantier, David A. Jacobson, Craig W. Lindsley and Jerod S. Denton
      Journal of Pharmacology and Experimental Therapeutics September 2019, 370 (3) 350-359; DOI: https://doi.org/10.1124/jpet.119.257204

  8. Breinholt, Vibeke Miller

    1. TransCon CNP, a Sustained-Release C-Type Natriuretic Peptide Prodrug, a Potentially Safe and Efficacious New Therapeutic Modality for the Treatment of Comorbidities Associated with Fibroblast Growth Factor Receptor 3–Related Skeletal Dysplasias
      Vibeke Miller Breinholt, Caroline E. Rasmussen, Per Holse Mygind, Mads Kjelgaard-Hansen, Frank Faltinger, Ana Bernhard, Joachim Zettler and Ulrich Hersel
      Journal of Pharmacology and Experimental Therapeutics September 2019, 370 (3) 459-471; DOI: https://doi.org/10.1124/jpet.119.258251

  9. Breitenbucher, J. Guy

    1. Target Engagement of a Phosphodiesterase 2A Inhibitor Affecting Long-Term Memory in the Rat
      Guibao Gu, Trevor Scott, Yingzhuo Yan, Noelle Warren, Adia Zhang, Ali Tabatabaei, Hao Xu, Kathleen Aertgeerts, Laurent Gomez, Andrew Morse, Yu-Wen Li, J. Guy Breitenbucher, Eben Massari, Jeffrey Vivian and Anne Danks
      Journal of Pharmacology and Experimental Therapeutics September 2019, 370 (3) 399-407; DOI: https://doi.org/10.1124/jpet.118.255851

  10. Brennan, Eoin P.

    1. Liraglutide Attenuates Preestablished Atherosclerosis in Apolipoprotein E–Deficient Mice via Regulation of Immune Cell Phenotypes and Proinflammatory Mediators
      Robyn Bruen, Seán Curley, Sarina Kajani, Gina Lynch, Marcella E. O’Reilly, Eugène T. Dillon, Eoin P. Brennan, Mary Barry, Stephen Sheehan, Fiona C. McGillicuddy and Orina Belton
      Journal of Pharmacology and Experimental Therapeutics September 2019, 370 (3) 447-458; DOI: https://doi.org/10.1124/jpet.119.258343
« Previous (Pages : 1 2 3 4 5 6 7 8 ... 33) Next »
Back to top

In this issue

Advertisement